SCHEMBL2431072

SCHEMBL2431072

COc1ccc(Br)c(C)c1OC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TUBB1 Q9H4B7 2/20 0.42
NQO2 P16083 2/20 0.42
KDM4E B2RXH2 2/20 0.42
ALDH1A1 P00352 2/20 0.42
CA2 P00918 1/20 0.41
CA4 P22748 1/20 0.41
LMNA P02545 2/20 0.40
MAPK1 P28482 2/20 0.40
ADRA2A P08913 2/20 0.40
ADRA2C P18825 2/20 0.40
ADRA1D P25100 2/20 0.40
ADRA1A P35348 2/20 0.40
ADRA1B P35368 2/20 0.40
MAPT P10636 2/20 0.40
HPGD P15428 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
ERN1 O75460 1/20 0.40
ACHE P22303 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ADRA2B P18089 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1829968 0.86 NQO2 (0.44) TUBB1NQO2KDM4EALDH1A1CA2
SCHEMBL9292546 0.83 NQO2 (0.42) TUBB1NQO2KDM4EALDH1A1CA2
SCHEMBL147312 0.82 TUBB1 (0.46) TUBB1NQO2KDM4EALDH1A1MAPT
SCHEMBL30171329 0.81 CA2 (0.50) TUBB1NQO2KDM4EALDH1A1CA2
SCHEMBL772484 0.81 CA2 (0.50) TUBB1NQO2KDM4EALDH1A1CA2
SCHEMBL9669244 0.80 ALDH1A1 (0.47) KDM4EALDH1A1CA2CA4LMNA
SCHEMBL10138847 0.79 TUBB1 (0.39) TUBB1NQO2KDM4EALDH1A1CA2
SCHEMBL1628136 0.79 CA2 (0.54) TUBB1NQO2KDM4EALDH1A1CA2
SCHEMBL287639 0.79 CA2 (0.38) TUBB1NQO2KDM4EALDH1A1CA2
SCHEMBL8071106 0.79 NQO2 (0.43) TUBB1NQO2KDM4EALDH1A1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8575161-B2 Benzofurane, benzothiophene, benzothiazol derivatives as FXR modulators MERCK PATENT GMBH (DE) 2013-11-05 US disclosed
US-8440643-B2 Inhibitors of beta-lactamase METHYLGENE INC. (CA) 2013-05-14 US disclosed
US-8067462-B2 Processes of making sesquiterpenoid tashironin, its analogs and their uses THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2011-11-29 US disclosed
US-8067462-B2 Processes of making sesquiterpenoid tashironin, its analogs and their uses THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2011-11-29 US disclosed
US-8012956-B2 Tropane compounds EXELIXIS, INC. (US) 2011-09-06 US disclosed
US-20110105475-A1 BENZOFURANE, BENZOTHIOPHENE, BENZOTHIAZOL DERIVATIVES AS FXR MODULATORS MERXCK PATENT GESELLSCHAFT (DE) 2011-05-05 US disclosed
EP-2074120-B1 TROPANE COMPOUNDS EXELIXIS INC (US) 2010-03-03 EP disclosed
EP-2074120-A1 TROPANE COMPOUNDS Exelixis, Inc. (US) 2009-07-01 EP disclosed
US-20090163471-A1 Tropane compounds EXELIXIS, INC. 2009-06-25 US disclosed
WO-2009055077-A1 TROPANE COMPOUNDS EXELIXIS, INC. (US) 2009-04-30 WO disclosed
US-20090105332-A1 PROCESSES OF MAKING SESQUITERPENOID TASHIRONIN, ITS ANALOGS AND THEIR USES THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF (US) 2009-04-23 US disclosed
US-20090105332-A1 PROCESSES OF MAKING SESQUITERPENOID TASHIRONIN, ITS ANALOGS AND THEIR USES THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF (US) 2009-04-23 US disclosed
EP-0980350-A4 HYDROXYNAPHTHOIC ACIDS AND DERIVATIVES UNIV NEW MEXICO (US) 2003-01-02 EP disclosed
US-6124498-A Hydroxynaphthoic acids and derivatives UNIVERSITY OF NEW MEXICO (US) 2000-09-26 US disclosed
EP-0980350-A2 HYDROXYNAPHTHOIC ACIDS AND DERIVATIVES The University of New Mexico (US) 2000-02-23 EP disclosed
WO-1998049130-A2 HYDROXYNAPHTHOIC ACIDS AND DERIVATIVES THE UNIVERSITY OF NEW MEXICO (US) 1998-11-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090163471-A1 Tropane compounds ADRA1B, ADRA2B, ADRB2 TUBB1 72/4885NQO2 1187/4885KDM4E 4402/4885
US-20110105475-A1 BENZOFURANE, BENZOTHIOPHENE, BENZOTHIAZOL DERIVATIVES AS FXR MODULATORS FXR1, FXR2, NR1H4 TUBB1 1369/4885NQO2 1276/4885KDM4E 2944/4885
US-20090105332-A1 PROCESSES OF MAKING SESQUITERPENOID TASHIRONIN, ITS ANALOGS AND THEIR USES OXER1, OXSR1, BRS3 TUBB1 2189/4885NQO2 862/4885KDM4E 3084/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.